论文部分内容阅读
Objective: To describe the use of botulinum toxin injection of the lacrimal gland for palliative treatment of epiphora secondary to canalicular obstruction from docetaxel therapy. Design: Case report. Intervention: A 50- year-old female with bilateral canalicular obstruction secondary to docetaxel therapy received botulinum toxin injections (5 units each) into the lacrimal glands of both eyes. Results: Symptomatic epiphora of the affected eyes was reduced after 2 weeks. No side effects were observed. Conclusions: Botulinum toxin injection of the lacrimal gland is an effective palliative treatment for epiphora secondary to canalicular obstruction from docetaxel therapy.
Objective: To describe the use of botulinum toxin injection of the lacrimal gland for palliative treatment of epiphora secondary to canalicular obstruction from docetaxel therapy. Design: Case report. Intervention: A 50-year-old female with bilateral canalicular obstruction secondary to docetaxel therapy received Botulinum toxin injections (5 units each) into the lacrimal glands of both eyes. Results: Symptomatic epiphora of the affected eyes was reduced after 2 weeks. No side effects were observed. Conclusions: Botulinum toxin injection of the lacrimal gland is an effective palliative treatment for epiphora secondary to canalicular obstruction from docetaxel therapy.